Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut
(Reuters) – Shares of Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna, slumped 32% in their…
Month: February 2024
Pinterest’s weak forecast signals intense competition for ad dollars
By Jaspreet Singh (Reuters) – Pinterest forecast first-quarter revenue largely below Wall Street estimates on Thursday, a sign that it…
Exclusive-Trump’s media deal partner nears $50 million financing -sources
By Anirban Sen (Reuters) – Digital World Acquisition Corp, the blank-check acquisition company that has agreed to take former U.S.…
NYCB gets third credit downgrade as CRE exposure worries spill to Europe
By Manya Saini and Niket Nishant (Reuters) -Embattled New York Community Bancorp faced its third credit-rating cut on Thursday while…
Explainer-What is next for Donald Trump at the US Supreme Court?
By John Kruzel and Andrew Chung WASHINGTON (Reuters) – The U.S. Supreme Court on Thursday seemed poised to rule in…
S&P 500 closes at record as yields rise, dollar retreats
By Chris Prentice and Amanda Cooper NEW YORK/LONDON (Reuters) -Global equities climbed to a more than two-year peak and the…
Biden aides to meet with Arab, Muslim leaders in Michigan on Gaza
By Andrea Shalal WASHINGTON (Reuters) – Senior U.S. officials will visit the 2024 election battleground state of Michigan on Thursday…
Fed policymakers signal no rush to cut US interest rates
By Lindsay Dunsmuir and Michael S. Derby (Reuters) – U.S. central bankers want to hold off on cutting interest rates…
Oil climbs on US fuel stocks draw, geopolitical tensions
By Georgina McCartney HOUSTON (Reuters) -Oil prices rose for a third consecutive day on Wednesday, boosted by a larger-than-expected fall…
Novartis to acquire cancer-focused MorphoSys for $2.9 billion
(Reuters) -Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros ($2.9…